Your Brain May Be Working Against You When It Comes to Sex.

Couple in bed

Hypoactive sexual desire disorder (HSDD) is the most common form of sexual dysfunction in women.1 There hasn’t been a treatment until now.

Speak with a doctor today from the privacy of your own home

MEET: Addyi

Addyi is the first and only FDA-approved treatment for acquired, generalized hypoactive (low) sexual desire disorder—HSDD—in women who have not gone through menopause. Symptoms of HSDD include low libido and associated distress.

Addyi Packaging
Healthy Brain HSDD Brain

Lack of sexual desire can have a biological basis.

A medical condition, known as Hypoactive Sexual Desire Disorder (HSDD), is evident on brain scan imaging when women diagnosed with the condition are exposed to sexual cues.2,3,4,5

Could You have HSDD?

To understand what HSDD is, it's also important to understand what HSDD is not.

HSDD

  • You were satisfied in the past with your desire for sex
  • Your desire for sex has decreased
  • Your decreased desire for sex has persisted for 6 months or more
  • Your decreased desire for sex is bothering you

Healthy (Not HSDD)

  • HSDD is not a lack of desire for sex due to relationship issues
  • HSDD is not a lack of desire for sex caused by a medical or mental health issue
  • HSDD is not a lack of desire for sex caused by a medication that you are taking

About Addyi

Addyi Bottle and Pill

Addyi is a prescription non-hormonal pill taken every day at bedtime. It is the only FDA approved treatment for Hypoactive Sexual Desire Disorder (HSDD). Addyi is believed to work on the part of the brain involved in sexual motivation and response though it’s exact mechanism of action is not fully understood.6 In clinical studies with ADDYI, some women experienced improvement in one or more of their HSDD symptoms,6,7,8,9 including:

  • INCREASED sexual desire
  • INCREASED number of times in a month that a woman had satisfying sexual intercourse or engaged in other satisfying sexual activity, such as oral sex, masturbation, or genital stimulation by a partner
  • DECREASED distress associated with low sexual desire

Not all women will experience similar improvement in their HSDD. Speak with your doctor about the benefits and the risks associated with taking Addyi. See IMPORTANT SAFETY INFORMATION below. Addyi is not FEMALE Viagra.

Desire is in the brain.

GetAddyiNow

Right fit for you?

Is Addyi right for you?

Speak with a US licensed doctor* from the privacy of your own home.

Free home delivery box

Free home delivery of Addyi for
as little as $25/month**

Connect with a doctor
By clicking here you will leave addyi.com and go to the telemedicine provider

  • *The $49 doctor consult and free home delivery are through third party providers.
  • **Should your insurer not cover Addyi or you’re uninsured, you’ll never pay more than $99/month.

Frequently Asked Questions

  • What is telemedicine?

  • How much does Addyi cost?

  • How does the online doctor visit work?

  • Are the online doctors licensed?

  • What is the consult fee for? Is it covered by my insurance?

  • Can I use my FSA/HSA Debit Card?

  • Will my insurance cover Addyi ordered through the GET ADDYI NOW online service?

  • What is the home delivery pharmacy option provided through the GET ADDYI NOW online service?

  • I already use Addyi, can I transfer my prescription to the home delivery pharmacy?

  • My local doctor wrote a prescription for Addyi. How can I take advantage of the free home delivery pharmacy option?

References: 1. Shifren JL, Monz BU, Russo PA, et al. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112(5):970-8. 2. Holstege G, Weijmar- Schultz W. How combined serotonin-1A receptor agonist and 2A- receptor antagonist can heal hypoactive sexual desire disorder (HSDD). Poster presented at Neuroscience 2014 the Society for Neuroscience 2014 Annual Meeting (SfN); November 15-19, 2014; Washington, DC. 3. Woodard TL, Nowak NT, Balon R, Diamond MP. Brain activation patterns in women with acquired hypoactive sexual desire disorder and women with normal sexual function: A cross-sectional pilot study. Fertil Steril. 2013; 100(4): 1068-1076. 4. Arnow BA, Millheiser L, Garrett A, et al. Women with hypoactive sexual desire disorder compared to normal females: A functional magnetic resonance imaging study. Neuroscience. 2009; 158:484-502. 5. Bianchi‐Demicheli F, Cojan Y, Waber L, Recordon N, Vuilleumier P, and Ortigue S. Neural bases of hypoactive sexual desire disorder in women: An event‐related fMRI study. J Sex Med 2011;8:2546–2559. 5. Bianchi‐Demicheli F, Cojan Y, Waber L, Recordon N, Vuilleumier P, and Ortigue S. Neural bases of hypoactive sexual desire disorder in women: An event‐related fMRI study. J Sex Med. 2011;8:2546–2559. 6. Stephen M. Stahl Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder. CNS Spectrums, Available on CJO 2015 doi:10.1017/S1092852914000832. 7. DeRogatis LR, Komer L, Katz M, et al; VIOLET trial investigators. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET study. J Sex Med. 2012;9(4):1074-1085. 8. Thorp J, Simon J, Dattani D, et al; DAISY trial investigators. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study. J Sex Med. 2012;9(3):793-804. 9. Katz M, DeRogatis LR, Ackerman R, et al. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial. J Sex Med. 2013;10(7):1807-1815.